Research overview · Compound
Cagrilintide (10mg)
What is Cagrilintide (10mg)?
Cagrilintide is often used to enhance the effects of Retatrutide. A long-acting synthetic analog of the natural hormone amylin. It is primarily studied for obesity and weight management.
How It Works Mechanism: It activates both amylin and calcitonin receptors in the hypothalamus, curbing cravings and reducing food intake. Amylin vs. GLP-1: Unlike GLP-1 agonists (such as semaglutide) which affect incretin pathways, cagrilintide operates via a completely separate, additive satiety signal. Clinical Research and EfficacyMonotherapy: In phase 3 clinical trials, cagrilintide alone has demonstrated meaningful body-weight reductions. Combination Therapy: Its most widely researched application is in combination with semaglutide and Retatrutide. Trial data for this dual-mechanism pairing suggests substantial weight reductions.
Documentation
Documentation status for Cagrilintide (10mg) is shown on its product record.
Frequently asked questions
- What is Cagrilintide (10mg)?
- Cagrilintide (10mg) is a research compound supplied by East Coast Labs strictly for laboratory research use only. It is not for human or veterinary use.
- Is Cagrilintide (10mg) for human use?
- No. Cagrilintide (10mg) is supplied for laboratory research use only and is not intended for human or veterinary use, consumption, or therapeutic application.